Smoore's 2023 Annual Performance: Strong Growth and Global Expansion

Business by 2FIRSTS.ai
Mar.18.2024
Smoore's 2023 Annual Performance: Strong Growth and Global Expansion
Smoore (06969.HK) announced its 2023 annual performance with a total revenue of 11.17 billion RMB, focusing on global expansion.

On March 18th, Smoore (06969.HK) released its full-year performance for 2023, with total annual revenue reaching 11.17 billion Chinese Yuan (around 1.6 billion USD). Smoore has continued to strengthen its localized layout in overseas markets, with its self-owned brands showing sustained growth and healthy increases in overseas revenue. At the same time, the company has been working on improving management efficiency and cost-effectiveness. In the future, it plans to transform into a globalized enterprise, laying the foundation for future growth.

 

Smoore's 2023 Annual Performance: Strong Growth and Global Expansion
Source: Smoore International Holdings Limited

 

Smoore International's Chairman of the Board, Chen Zhiping, stated, "In the past year, our operations in different regions have shown significant differences due to the impact of market regulations and external environments. Thanks to our continuous efforts to expand our global presence and enhance local operational management capabilities, our overseas market revenues have continued to grow steadily throughout the year. We believe that the ongoing updates to electronic vapor product regulations worldwide and the further strengthening of enforcement will benefit the industry's long-term sustainable development, and we are confident in the bright future of the vaping business."

 

Smoore's 2023 Annual Performance: Strong Growth and Global Expansion
Source: Smoore International Holdings Limited

 

Overseas Market Experiencing Stable Growth, Revenue Accounting for over 90%

 

Smoore, an e-cigarette company, actively expands its presence in overseas markets, with steady growth in overseas revenues reaching 11.01 billion RMB, a 11.2% increase from 2022. The market share of disposable products has significantly increased in multiple countries, and the US market has helped strategic clients maintain the top market share in the closed-system pod category. The company's own brand is leading in key global markets.

 

In Europe and other markets, Smoore launched an upgraded ceramic atomization core disposable technology platform, FEELM Max, in 2023. This platform allows for more puffs under compliant liquid volume regulations. The technology platform has successfully entered the supply chain of major customers, achieving large-scale shipments and receiving wide praise from customers and users. The group's disposable products achieved revenue of 3.37 billion yuan, a significant increase of 74.5% compared to 2022, with the revenue accounting for 30.2% of total revenue, up from 15.9% in the same period last year.

 

Targeting the U.S. market, the group has successfully helped strategic clients maintain their leading market share in the category of closed pod-system products in the U.S. market by improving production intelligence level, optimizing cost structure, and other measures, and further increasing market share.

 

The self-owned brand VAPORESSO upholds the brand genes of "innovation, high quality", achieving revenue of 1.85 billion RMB, a 26.0% increase compared to the same period last year. VAPORESSO is currently in a leading position in the global leading market, continuously increasing market share in the open category market. In terms of marketing, they have completed the digitization management of their marketing channels, increased efforts in expanding overseas markets, established local teams in major markets, continuously enhanced consumer insights, ensured meeting the diverse needs of consumers, and quickly pushed towards retail terminals. VAPORESSO COSS products have won the prestigious Golden Leaf Award in the global atomization field, becoming the first open brand in the industry to receive the Golden Leaf Award.

 

Strengthen R&D Management System, while Improving Operational Efficiency

 

In terms of research and development, the group has increased its R&D investment. R&D expenses for the year amount to 14.8 billion yuan, accounting for approximately 13.3% of revenue, continuing to enhance the group's technological leadership in the atomization field. In the field of electronic atomization, the FEELM Max technology platform has been launched. In the HNB field, the group has successfully introduced a variety of competitive heating technology product platforms, significantly improving the user experience and taste.

 

In terms of marketing, the group continuously enhances its user insights and channel control capabilities, establishes localized marketing teams and store management systems, and innovates customer cooperation models to provide customers with value-added services such as market insights and promotion. The group operates multiple overseas warehouses in Europe and America, and has established several overseas sales and research and development centers. The global layout is beneficial for the group to be close to consumers, understand market trends, and also helps to be closer to customers, save costs, and improve delivery speed.

 

Continuing to streamline operations and increase efficiency in internal management. By implementing the Amoeba management model, strengthening budget management systems, and leveraging the advantages of group information systems, operational efficiency has continued to improve, resulting in a significant decrease in management expenses during the review period.

 

Provide Cutting-edge Atomization Solutions with Focus on User Experience

 

In the field of electronic atomization, in response to the rapid rise of disposable products worldwide, the group will continue to rely on leading technology, precise user insights, and sinking sales channels to launch innovative products with differentiation and quickly capture the disposable market. Regarding pod-system products, the group will continue to support customers' product iteration needs and help customers continue to increase market share. As for open system products, the group will continue to enhance user insights and channel control capabilities, timely introduce more innovative products, and achieve sustained and stable growth in this category.

 

In the field of HNB products, the group has already established a leading technology reserve with differentiation, and will continuously seek to collaborate with other industry leaders in the future to jointly develop new products and expand market coverage. In 2024, further product refinements will be made to lay a solid foundation for commercialization.

 

Mr. Chen Zhiping concluded that in the future, the group will focus on the field of atomization, continue to increase product development, while continuously improving operational efficiency and marketing capabilities. The goal is to create greater value for customers and consumers with leading technology and innovative products, and provide shareholders with sustained returns through healthy business performance.

 

Source: International Smoore

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
Retail Case Study | Wisconsin Vape Market One Year After New Regulations: Johnny Vapes Reports 80% Sales Decline as Consumers Shift Online and Across State Lines
According to WNCY on August 24, 2026, some independent vape retailers in Wisconsin say they have faced significant business pressure one year after new vape regulations took effect. Johnny Vapes, a retailer operating in northeast Wisconsin, said its store count fell from seven locations to four, sales declined by about 80%, and roughly 90% of its inventory was affected. Retailers said some consumers have shifted to online purchases or traveled to neighboring Michigan to buy vape products. The case highlights how local regulations can reshape retail operations, inventory management and consumer purchasing patterns.
Aug.28
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives